Stay updated on Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Sign up to get notified when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    The site footer now identifies the website as revision v3.8.1 instead of v3.8.0.
    Difference
    0.0%
    Check dated 2026-11-18T01:51:11.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    The study record for the rilzabrutinib Phase 2 trial is displayed instead of an error page, with detailed trial information and links to results-related publications and study documents.
    Difference
    100%
    Check dated 2026-11-11T01:07:30.000Z thumbnail image
  3. Check
    19 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.2 to v3.8.0. The study record continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-11-03T23:19:19.000Z thumbnail image
  4. Check
    33 days ago
    Change Detected
    Summary
    A notice about NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” appears above the page, and the site revision changes from v3.7.1 to v3.7.2. The study record itself remains unavailable behind a 403 error.
    Difference
    1%
    Check dated 2026-10-20T22:50:20.000Z thumbnail image
  5. Check
    47 days ago
    Change Detected
    Summary
    The site footer revision changed from v3.7.0 to v3.7.1. The page continues to show a 403 Forbidden error instead of the study record.
    Difference
    0.2%
    Check dated 2026-10-06T23:10:13.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    A 403 Forbidden error page appears when attempting to view the study record, showing a 403 message. A Home button is present, indicating restricted access rather than the study content.
    Difference
    17%
    Check dated 2026-09-22T23:55:52.000Z thumbnail image

Stay in the know with updates to Rilzabrutinib for CSU: H1 Resistant - Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Rilzabrutinib for CSU: H1 Resistant - Clinical Trial page.